title: ADP receptor-blocker thienopyridines: chemical structures, mode of action and clinical use. A review.
abstract: One of the major classes of adenosine diphosphate (ADP) receptor antagonists are thienopyridines. Thienopyridines compose a subcategory of antiplatelet medications, known as ADP receptor inhibitors, used commonly for the treatment of atherosclerotic cardiovascular disease. Thienopyridines, including ticlopidine, clopidogrel and prasugrel, are prodrugs administered orally that are further metabolized by hepatocytes to create active metabolites that irreversibly bind ADP receptors located on the platelet membrane. Thus, these selected drugs have an inhibitory effect for the duration of the platelet's lifespan of 7-10 days. The goal of this manuscript is to review the currently available ADP receptor blockers with emphasis on chemical structure, mode of action and clinical use.
authors: University of Arizona Sarver Heart Center, 1501 North Campbell Avenue, Tucson, AZ, 85724, USA. mhashemzadeh@shc.arizona.edu
authors: Mehrnoosh
authors: M
authors: Hashemzadeh
authors: Sarah
authors: S
authors: Goldsberry
authors: Matthew
authors: M
authors: Furukawa
authors: Ali
authors: A
authors: Khoynezhad
authors: Mohammad Reza
authors: MR
authors: Movahed
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D058919:Purinergic P2 Receptor Antagonists; D011725:Pyridines / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D011725:Pyridines; C446540:thienopyridine